PropertyValue
?:abstract
  • Small cell glioblastoma (scGBM) is a rare histological variant of classical glioblastoma (GBM). Presence of necrosis and microvascular proliferation is not essential for the diagnosis. It is thought to have more aggressive behavior as compared with classical GBM; however, because of its rarity standard treatment guidelines are not available. Adjuvant treatment for these cancers consists of postoperative radiotherapy with concurrent and maintenance temozolomide similar to classical GBM. Here we present a case series of five small cell glioblastoma patients along with the clinical-pathological review.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.2217/cns-2020-0016
?:journal
  • CNS_oncology
?:license
  • cc-by-nc-nd
?:pdf_json_files
  • document_parses/pdf_json/eb8394e81be76ba6046783622668fa2effae86e6.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7737196.xml.json
?:pmcid
?:pmid
?:pmid
  • 33283529.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Small cell glioblastoma multiforme: a case series and clinicopathological update
?:type
?:year
  • 2020-12-07

Metadata

Anon_0  
expand all